Journal of Cancer Research and Therapeutics Close
 

Figure 4: Kidney IHC-caspase-3: (a) Control untreated rats: very weak cytoplasmic staining of tubular epithelium. (b) BME-treated rats: moderate tubular cytoplasmic staining. (c) Cisplatin-treated rats: intense tubular cytoplasmic staining. (d) Cisplatin and BME co-treated rats: more intense positive staining (×400)

Figure 4: Kidney IHC-caspase-3: (a) Control untreated rats: very weak cytoplasmic staining of tubular epithelium. (b) BME-treated rats: moderate tubular cytoplasmic staining. (c) Cisplatin-treated rats: intense tubular cytoplasmic staining. (d) Cisplatin and BME co-treated rats: more intense positive staining (×400)